Ardent Health Reports Strong Q1 Results with 26% Adjusted EBITDA Growth; Reaffirms Full-Year Guidance

summarizeSummary

Ardent Health, Inc. announced strong first-quarter 2026 financial results, including a 7.0% increase in total revenue and a 26.3% rise in Adjusted EBITDA, while reaffirming its full-year guidance.

check_boxKey Events

• Strong Q1 Financial Performance

  Total revenue increased 7.0% year-over-year to $1.60 billion, and Adjusted EBITDA grew 26.3% year-over-year to $124 million for the first quarter ended March 31, 2026.

• Full-Year Guidance Reaffirmed

  The company reaffirmed its full-year 2026 financial guidance, projecting total revenue between $6,400 million and $6,700 million and Adjusted EBITDA between $485 million and $535 million.

• Operational Growth Despite Headwinds

  Adjusted admissions increased by 2.0% and total surgeries grew by 1.2% year-over-year, despite a slight decrease in overall admissions attributed to severe weather and a lighter respiratory season.

auto_awesomeAnalysis

Ardent Health, Inc. delivered a robust first quarter, marked by significant growth in Adjusted EBITDA and revenue, which signals strong operational execution. The reaffirmation of full-year guidance, despite some transient seasonal volume impacts, indicates management's confidence in sustained performance. This positive financial update, following closely on the heels of a Reuters report, provides investors with detailed confirmation of the company's solid start to the year and its outlook.